Has Peter Orio, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,842,574 in general payments to Peter Orio, DO across 431 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Orio, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Orio, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Orio, DO

Radiation Oncology · Boston, MANPI 1174639736

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,450,221 of the $1,842,574 with a category attached, or 78.7%. Teleflex LLC accounts for 61.1% of it on its own, with 17 other manufacturers making up the rest. Among radiation oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,842,574in general payments, 2019–2025

Across 431 payments — averaging $4275.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$1.1M
Palette Life Sciences, Inc.$409K
Theragenics Corporation$213K
Boston Scientific$37K
Accuray Incorporated$20K
Janssen Scientific Affairs, LLC$13K
plus $24K from 12 others

$15,840in ownership & investment interests, 2019–2025

Across 1 payment — averaging $15,840 each. An ownership or investment interest held by the physician or an immediate family member.

GT Medical Technologies, Inc$16K

What the payments were for

Consulting fees$1,450,22179%
Speaking & faculty fees$269,61515%
Travel & lodging$68,0184%
Food & beverage$13,4361%
Education$5,0000%
Gifts$1020%
Entertainment$280%
Ownership interest$14,2291%
Other$21,9231%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	226	$1,126,551
Palette Life Sciences, Inc.	54	$408,866
Theragenics Corporation	37	$212,967
Boston Scientific	18	$37,230
Accuray Incorporated	21	$20,185
Janssen Scientific Affairs, LLC	15	$13,211
Augmenix, Inc.	1	$8,000
Nucletron Operations B.v.	5	$4,031
GT Medical Technologies, Inc	11	$3,188
Isoray, Inc	19	$2,512
Blue Earth Diagnostics	7	$2,509
Varian Medical Systems, Inc.	2	$2,089
Elekta, Inc.	6	$361
Arrow International, Inc.	4	$228
Bioprotect Medical, Inc.	2	$223
Myriad Genetic Laboratories, Inc.	1	$200
Bard Peripheral Vascular, Inc.	1	$127
Astellas Pharma US Inc	1	$93

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Barrigel$541,502
GENERAL - THERAPIES$32,937
CyberKnife System$18,833
TomoTherapy System$14,539
Erleada$12,769
SPACEOAR$8,000
FLEXITRON HDR$3,398
Esteya$3,398
MICROSELECTRON DIGITAL$3,398
GammaTile$3,054
POSLUMA$2,311
Brachytherapy Source$2,026
BrachyVision$2,000
UroLift$1,900
ELEKTA MEDICAL LINEAR ACCELERATOR$758
SpaceOAR VUE System - 10mL$450
Prolaris$200
BIOPROTECT BALLOON IMPLANT SYSTEM$131
Model 200 TheraSeed Palladium-103 in ReadyLink$127
GENERAL ONCOLOGY$127

How this compares

$1,842,574 in reported general payments places this provider in the 95th percentile of 200 radiation oncology providers in Massachusetts.

See all radiation oncology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$127,086

Medicare patients

142

Services billed

1,191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	22	$323

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Boston

Paul NguyenBoston$721K
Jason EfstathiouBoston$156K
Jonathan SchoenfeldBoston$53K
Martin KingBoston$37K
Raymond MakBoston$36K
Shannon MacdonaldBoston$33K
Nima AghdamBoston$29K
Rachel JimenezBoston$28K
Theodore HongBoston$24K
Alice HoBoston$22K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →